Related Experiment Video
Updated: May 28, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
A novel role for matrix metalloproteinase-8 in sepsis
Patrick D Solan1, Katherine E Dunsmore, Alvin G Denenberg
1Department of Surgery, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, Cincinnati, OH, USA.
Objectives:
Matrix metalloproteinase-8 messenger RNA expression was previously found to be increased in whole blood of children with septic shock. The impact of this finding on the severity and inflammatory response to sepsis is unknown. Here, we investigate the relationship between matrix metalloproteinase-8 and disease severity in children with septic shock. We further corroborate the role of matrix metalloproteinase-8 in sepsis in a murine model.
Design:
Retrospective observational clinical study and randomized controlled laboratory experiments.
Setting:
Pediatric intensive care units and an animal research facility at an academic children's hospital.
Patients And Subjects:
Patients age ≤10 yrs admitted to the intensive care unit with a diagnosis of septic shock. For laboratory studies, we utilized male mice deficient for matrix metalloproteinase-8 and male wild-type C57BL/6J mice.
Interventions:
Blood from children with septic shock was analyzed for matrix metalloproteinase-8 messenger RNA expression and matrix metalloproteinase-8 activity, and correlated with disease severity based on mortality and degree of organ failure. A murine model of sepsis was used to explore the effect of genetic and pharmacologic inhibition of matrix metalloproteinase-8 on the inflammatory response to sepsis. Finally, activation of nuclear factor-κB was assessed both in vitro and in vivo.
Measurements And Main Results:
Increased matrix metalloproteinase-8 mRNA expression and activity in septic shock correlates with decreased survival and increased organ failure in pediatric patients. Genetic and pharmacologic inhibition of matrix metalloproteinase-8 leads to improved survival and a blunted inflammatory profile in a murine model of sepsis. We also identify matrix metalloproteinase-8 as a direct in vitro activator of the proinflammatory transcription factor, nuclear factor-κB.
Conclusions:
Matrix metalloproteinase-8 is a novel modulator of inflammation during sepsis and a potential therapeutic target.
Insights
Matrix metalloproteinase-8 (MMP-8) is linked to worse outcomes in pediatric septic shock. Inhibiting MMP-8 improved survival and reduced inflammation in a mouse model, suggesting it
Area of Science:
- Pediatric critical care medicine
- Immunology
- Molecular biology
Background:
- Matrix metalloproteinase-8 (MMP-8) mRNA expression is elevated in children with septic shock.
- The role of MMP-8 in sepsis severity and inflammation remains unclear.
Purpose of the Study:
- To investigate the association between MMP-8 and disease severity in pediatric septic shock.
- To explore the therapeutic potential of MMP-8 inhibition in sepsis using a murine model.
Main Methods:
- Retrospective analysis of pediatric septic shock patients (age ≤10 yrs).
- Laboratory experiments using MMP-8 deficient and wild-type mice.
- Assessment of MMP-8 mRNA, activity, organ failure, survival, and nuclear factor-κB activation.
Main Results:
- Increased MMP-8 expression and activity in pediatric septic shock correlated with higher mortality and organ failure.
- Genetic and pharmacologic MMP-8 inhibition improved survival and reduced inflammation in mice.
- MMP-8 was identified as a direct activator of the pro-inflammatory transcription factor nuclear factor-κB.
Conclusions:
- Matrix metalloproteinase-8 is a novel regulator of sepsis-induced inflammation.
- MMP-8 represents a potential therapeutic target for sepsis management.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Determinants of Bacterial Pathogenicity and Virulence
Acute Inflammation III: Local and Systemic Effects
Bacterial Meningitis II: Pathophysiology
